Is generic lenvatinib available ?

Short answer:
In the United States, a generic version of lenvatinib (sold under the brand name Lenvima) has not yet been approved by the FDA, so it isn’t available on U.S. drug formularies.

In other countries, however, a few generic manufacturers have obtained regulatory approval and the drug is sold under different trade names (e.g., Lenvat, Lenvatix, Lenvar, etc.). Availability and pricing vary by market and by the specific generic product.

What the FDA says

• Lenvima (lenvatinib) is still protected by U.S. patents that cover the drug’s formulation, method of use, and manufacturing process.
• The FDA has not yet cleared any generic submission for lenvatinib as of the latest public data (2026‑08).
• Because of the pending patents, generic manufacturers in the U.S. are currently unable to market lenvatinib without an exclusive license or a successful patent challenge.

Global landscape

The table reflects the most recent regulatory filings; some countries may have newer approvals that are not yet captured in the source documents.

Why it matters

• Patent protection keeps the branded product as the sole market option in the U.S. for the foreseeable future, often resulting in higher prices for patients and insurers.
• Generic availability abroad can provide a cost‑effective alternative for patients who can obtain the drug outside the U.S., or who are eligible for international insurance or travel‑medicine programs.

Practical next steps if you’re interested in a generic

1. Check your local regulatory agency (e.g., EMA in Europe, CIPA in India) for the most current status.
2. Speak with your prescribing clinician; they can inform you about any approved generics available in your country or region.
3. Ask your pharmacist; they can verify whether a generic formulation is stocked in your pharmacy network.

Bottom line: If you’re in the U.S., you’ll still be receiving Lenvima from the brand-name manufacturer until the FDA grants generic approval. If you’re elsewhere, a generic version may already be on the market—but check local approvals and consult your healthcare professional before switching.